Colrain Capital LLC Buys 11,695 Shares of Cigna Group $CI

Colrain Capital LLC boosted its stake in Cigna Group (NYSE:CI) by 52.0% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 34,195 shares of the health services provider’s stock after acquiring an additional 11,695 shares during the quarter. Cigna Group accounts for about 5.2% of Colrain Capital LLC’s portfolio, making the stock its 8th biggest holding. Colrain Capital LLC’s holdings in Cigna Group were worth $9,411,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently added to or reduced their stakes in CI. Norges Bank acquired a new stake in Cigna Group in the 4th quarter valued at $1,019,790,000. Northwestern Mutual Wealth Management Co. grew its stake in Cigna Group by 13,333.2% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 3,165,408 shares of the health services provider’s stock valued at $900,912,000 after acquiring an additional 3,141,844 shares during the period. Capital Research Global Investors grew its stake in Cigna Group by 140.2% in the 3rd quarter. Capital Research Global Investors now owns 3,179,301 shares of the health services provider’s stock valued at $916,434,000 after acquiring an additional 1,855,897 shares during the period. Massachusetts Financial Services Co. MA grew its stake in Cigna Group by 8.3% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 11,805,083 shares of the health services provider’s stock valued at $3,249,113,000 after acquiring an additional 903,334 shares during the period. Finally, Ameriprise Financial Inc. grew its stake in Cigna Group by 54.5% in the 3rd quarter. Ameriprise Financial Inc. now owns 2,136,311 shares of the health services provider’s stock valued at $615,781,000 after acquiring an additional 753,865 shares during the period. Institutional investors and hedge funds own 86.99% of the company’s stock.

Analyst Ratings Changes

Several brokerages have issued reports on CI. Raymond James Financial set a $340.00 target price on shares of Cigna Group in a research note on Friday, May 1st. Guggenheim lifted their target price on shares of Cigna Group from $334.00 to $338.00 and gave the stock a “buy” rating in a research note on Monday, May 4th. Royal Bank Of Canada lifted their target price on shares of Cigna Group from $333.00 to $337.00 and gave the stock an “outperform” rating in a research note on Friday, May 1st. UBS Group lifted their target price on shares of Cigna Group from $375.00 to $400.00 and gave the stock a “buy” rating in a research note on Friday, May 22nd. Finally, Deutsche Bank Aktiengesellschaft cut shares of Cigna Group from a “buy” rating to a “hold” rating and lowered their target price for the stock from $303.00 to $302.00 in a research note on Wednesday, May 20th. One research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $338.80.

Insider Activity at Cigna Group

In other news, CEO David Cordani sold 201,878 shares of Cigna Group stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the transaction, the chief executive officer owned 34,337 shares in the company, valued at $10,054,560.34. The trade was a 85.46% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is currently owned by corporate insiders.

Cigna Group Stock Down 0.4%

NYSE CI opened at $294.64 on Friday. Cigna Group has a 52 week low of $239.51 and a 52 week high of $338.89. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.69. The business’s fifty day simple moving average is $281.93 and its 200-day simple moving average is $277.87. The firm has a market cap of $77.94 billion, a PE ratio of 12.49, a P/E/G ratio of 1.14 and a beta of 0.28.

Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 EPS for the quarter, topping the consensus estimate of $7.60 by $0.19. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The business had revenue of $68.52 billion for the quarter, compared to analyst estimates of $66.29 billion. During the same quarter in the previous year, the firm earned $6.74 EPS. The company’s quarterly revenue was up 4.6% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, equities analysts anticipate that Cigna Group will post 30.39 earnings per share for the current year.

Cigna Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th will be issued a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a dividend yield of 2.1%. The ex-dividend date is Thursday, June 4th. Cigna Group’s payout ratio is currently 26.45%.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.